NYSE ARCA | ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index.
The underlying index is composed of common stocks ofU. S. pharmaceutical companies.
These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 5.24% |
| ABT | Abbott Laboratories | Healthcare | Medical Devices | 5.07% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 5.05% |
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 5.03% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 4.88% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 4.85% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 4.85% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 4.80% |
| BHC | Bausch Health Companies Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.90% |
| TARO | Taro Pharmaceutical Industries Ltd | Healthcare | Drug Manufacturers - Specialty & Generic | 3.59% |
| OCUL | Ocular Therapeutix Inc | Healthcare | Biotechnology | 3.49% |
| LQDA | Liquidia Technologies Inc | Healthcare | Biotechnology | 3.17% |
| LGND | Ligand Pharmaceuticals Incorporated | Healthcare | Biotechnology | 3.10% |
| ANIP | ANI Pharmaceuticals Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.06% |
| AMRX | Amneal Pharmaceuticals, Inc. Class A Common Stock | Healthcare | Drug Manufacturers - Specialty & Generic | 2.97% |
| INVA | Innoviva Inc | Healthcare | Biotechnology | 2.88% |
| AVDL | Avadel Pharmaceuticals PLC | Healthcare | Drug Manufacturers - Specialty & Generic | 2.82% |
| VTRS | Viatris Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.77% |
| COLL | Collegium Pharmaceutical Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.72% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 2.67% |